External research and development expense (including amounts with related parties)
ImmunityBio, Inc.·Business Segments·1 segment
Breakdown
Segments
Reportable SegmentView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $5.51M | $8.55M | $7.32M | $7.89M | $20.08M |
| Total | $5.51M | $8.55M | $7.32M | $7.89M | $20.08M |